FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Posey

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Activities & Behaviors

Co-author Network

Publications

TOP 3
Kimberly A Stigler; Craig A Erickson; Jennifer E Mullett; David J Posey; Christopher J McDougle
Paliperidone for irritability in adolescents and young adults with autistic disorder.
Erica B Bernhardt; David J Posey; Kelda H Walsh; Christopher J McDougle
Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation.
Craig Andrew Erickson; Arlene Kohn; Jennifer E Mullett; David J Posey; Kimberly A Stigler; Logan K Wink; Christopher J McDougle
A prospective open-label study of aripiprazole in fragile X syndrome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Posey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Kimberly A Stigler; Craig A Erickson; Jennifer E Mullett; David J Posey; Christopher J McDougle
Paliperidone for irritability in adolescents and young adults with autistic disorder.
Psychopharmacology 2012;223(2):237-45.
2011: Erica B Bernhardt; David J Posey; Kelda H Walsh; Christopher J McDougle
Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation.
Journal of clinical psychopharmacology 2011;31(5):673-5.
2011: Craig Andrew Erickson; Arlene Kohn; Jennifer E Mullett; David J Posey; Kimberly A Stigler; Logan K Wink; Christopher J McDougle
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology 2011;216(1):85-90.
2010: Craig Andrew Erickson; Kimberly A Stigler; David J Posey; Christopher J McDougle
Aripiprazole in autism spectrum disorders and fragile X syndrome.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2010;7(3):258-63.
2010: L Eugene Arnold; Cristan Farmer; Helena Chmura Kraemer; Mark Davies; Andrea N Witwer; Shirley Chuang; Robert A Disilvestro; Christopher J McDougle; James McCracken; Benedetto Vitiello; Michael G Aman; Lawrence Scahill; David J Posey; Naomi B Swiezy
Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability.
Journal of child and adolescent psychopharmacology 2010;20(2):83-93.
2010: James T McCracken; Michael G Aman; Christopher J McDougle; Elaine Tierney; Sharon Shiraga; Fiona Whelan; L Eugene Arnold; David J Posey; Louise Ritz; Benedetto Vitiello; Lawrence Scahill
Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity.
Journal of child and adolescent psychopharmacology 2010;20(1):1-5.
2009: Roumen N Nikolov; Karen E Bearss; Jelle Lettinga; Craig Erickson; MARIA RODOWSKI; Michael G Aman; James T McCracken; Christopher J McDougle; Elaine Tierney; Benedetto Vitiello; L Eugene Arnold; Bhavik Shah; David J Posey; Louise Ritz; Lawrence Scahill
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.
Journal of autism and developmental disorders 2009;39(3):405-13.
2008: David J Posey; Craig Andrew Erickson; Christopher J McDougle
Developing drugs for core social and communication impairment in autism.
Child and adolescent psychiatric clinics of North America 2008;17(4):787-801, viii-ix.
2008: David J Posey; Christopher J McDougle
Treating autism spectrum disorders. Preface.
Child and adolescent psychiatric clinics of North America 2008;17(4):xv-xviii.
2008: Michael G Aman; Jill A Hollway; Christopher J McDougle; Lawrence Scahill; Elaine Tierney; James T McCracken; L Eugene Arnold; Benedetto Vitiello; Louise Ritz; Allison Gavaletz; Pegeen Cronin; Naomi B Swiezy; Courtney Wheeler; Kathleen Koenig; Jaswinder K Ghuman; David J Posey
Cognitive effects of risperidone in children with autism and irritable behavior.
Journal of child and adolescent psychopharmacology 2008;18(3):227-36.
2008: Christopher J McDougle; Kimberly A Stigler; Craig Andrew Erickson; David J Posey
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
The Journal of clinical psychiatry 2008;69 Suppl 4():15-20.
2008: David J Posey; Kimberly A Stigler; Craig Andrew Erickson; Christopher J McDougle
Antipsychotics in the treatment of autism.
The Journal of clinical investigation 2008;118(1):6-14.
2007: Craig Andrew Erickson; David J Posey; Kimberly A Stigler; Christopher J McDougle
Pharmacologic treatment of autism and related disorders.
Pediatric annals 2007;36(9):575-85.
2007: Elaine Tierney; Michael Aman; David Stout; Krista Pappas; L Eugene Arnold; Benedetto Vitiello; Lawrence Scahill; Christopher J McDougle; James McCracken; Courtney Wheeler; Andres Martin; David J Posey; Bhavik Shah
Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study.
Psychopharmacology 2007;191(1):149-57.
2007: Craig Andrew Erickson; David J Posey; Kimberly A Stigler; Jennifer Mullett; Adrian R Katschke; Christopher J McDougle
A retrospective study of memantine in children and adolescents with pervasive developmental disorders.
Psychopharmacology 2007;191(1):141-7.
2007: David J Posey; Michael G Aman; James T McCracken; Lawrence Scahill; Elaine Tierney; L Eugene Arnold; Benedetto Vitiello; Shirley Z Chuang; Mark Davies; Yaser Ramadan; Andrea N Witwer; Naomi B Swiezy; Pegeen Cronin; Bhavik Shah; Deirdre H Carroll; Christopher Young; Courtney Wheeler; Christopher J McDougle
Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
Biological psychiatry 2007;61(4):538-44.
2007: george anderson; Lawrence Scahill; James T McCracken; Christopher J McDougle; Michael G Aman; Elaine Tierney; L Eugene Arnold; Andrés Martin; Liliya Katsovich; David J Posey; Bhavik Shah; Benedetto Vitiello
Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.
Biological psychiatry 2007;61(4):545-50.
2007: David J Posey; Christopher J McDougle
Guanfacine and guanfacine extended release: treatment for ADHD and related disorders.
CNS drug reviews 2007;13(4):465-74.
2006: Ronald L Lindsay; L Eugene Arnold; Michael G Aman; Benedetto Vitiello; David J Posey; Christopher J McDougle; Lawrence Scahill; Maryellen Pachler; James T McCracken; Elaine Tierney; Dawn Bozzolo
Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study.
Journal of intellectual & developmental disability 2006;31(4):204-9.
2006: Kimberly A Stigler; David J Posey; Christopher J McDougle
Ramelteon for insomnia in two youths with autistic disorder.
Journal of child and adolescent psychopharmacology 2006;16(5):631-6.
2006: David J Posey; Ryan E Wiegand; Jennifer Wilkerson; Melissa Maynard; Kimberly A Stigler; Christopher J McDougle
Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.
Journal of child and adolescent psychopharmacology 2006;16(5):599-610.
2006: Lawrence Scahill; Michael G Aman; Christopher J McDougle; James T McCracken; Elaine Tierney; James Dziura; L Eugene Arnold; David J Posey; Christopher Young; Bhavik Shah; Jaswinder K Ghuman; Louise Ritz; Benedetto Vitiello
A prospective open trial of guanfacine in children with pervasive developmental disorders.
Journal of child and adolescent psychopharmacology 2006;16(5):589-98.
2006: Lawrence Scahill; Christopher J McDougle; Susan K Williams; Anastasia Dimitropoulos; Michael G Aman; James T McCracken; Elaine Tierney; L Eugene Arnold; Pegeen Cronin; Grados Marco; Jaswinder K Ghuman; Kathleen Koenig; Kristen S L Lam; James J McGough; David J Posey; Louise Ritz; Naomi B Swiezy; Benedetto Vitiello
Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(9):1114-23.
2006: Luc Lecavalier; Michael G Aman; Lawrence Scahill; Christopher J McDougle; James T McCracken; Benedetto Vitiello; Elaine Tierney; L Eugene Arnold; Jaswinder K Ghuman; Rachel L. Loftin; Pegeen Cronin; Kathleen Koenig; David J Posey; Andres Martin; Jill Hollway; Lisa S Lee; Alice S M Kau
Validity of the autism diagnostic interview-revised.
American journal of mental retardation : AJMR 2006;111(3):199-215.
2006: Susan K Williams; Lawrence Scahill; Benedetto Vitiello; Michael G Aman; L Eugene Arnold; Christopher J McDougle; James T McCracken; Elaine Tierney; Louise Ritz; David J Posey; Naomi B Swiezy; Jill Hollway; Pegeen Cronin; Jaswinder K Ghuman; Courtney Wheeler; Domenic Cicchetti; Sara S Sparrow
Risperidone and adaptive behavior in children with autism.
Journal of the American Academy of Child and Adolescent Psychiatry 2006;45(4):431-9.
2006: David J Posey; Craig Andrew Erickson; Kimberly A Stigler; Christopher J McDougle
The use of selective serotonin reuptake inhibitors in autism and related disorders.
Journal of child and adolescent psychopharmacology 2006;16(1-2):181-6.
2005: Michael G Aman; L Eugene Arnold; Christopher J McDougle; Benedetto Vitiello; Lawrence Scahill; Mark Davies; James T McCracken; Elaine Tierney; Patricia L Nash; David J Posey; Shirley Chuang; Andres Martin; Bhavik Shah; Nilda M Gonzalez; Naomi B Swiezy; Louise Ritz; Kathleen Koenig; James J McGough; Jaswinder K Ghuman; Ronald L Lindsay
Acute and long-term safety and tolerability of risperidone in children with autism.
Journal of child and adolescent psychopharmacology 2005;15(6):869-84.
2005: Benedetto Vitiello; Mark Davies; L Eugene Arnold; Christopher J McDougle; Michael Aman; James T McCracken; Lawrence Scahill; Elaine Tierney; David J Posey; Naomi B Swiezy; Kathleen Koenig
Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.
Journal of clinical psychopharmacology 2005;25(6):565-9.
2005: Craig Andrew Erickson; Kimberly A Stigler; Mark R Corkins; David J Posey; Joseph F Fitzgerald; Christopher J McDougle
Gastrointestinal factors in autistic disorder: a critical review.
Journal of autism and developmental disorders 2005;35(6):713-27.
2005: Craig Andrew Erickson; Kimberly A Stigler; David J Posey; Christopher J McDougle
Risperidone in pervasive developmental disorders.
Expert review of neurotherapeutics 2005;5(6):713-9.
2005: Christopher J McDougle; Lawrence Scahill; Michael G Aman; James T McCracken; Elaine Tierney; Mark Davies; L Eugene Arnold; David J Posey; Andrès Martin; Jaswinder K Ghuman; Bhavik Shah; Shirley Z Chuang; Naomi B Swiezy; Nilda M Gonzalez; Jill Hollway; Kathleen Koenig; James J McGough; Louise Ritz; Benedetto Vitiello
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
The American journal of psychiatry 2005;162(6):1142-8.
2005: Christopher J McDougle; Craig Andrew Erickson; Kimberly A Stigler; David J Posey
Neurochemistry in the pathophysiology of autism.
The Journal of clinical psychiatry 2005;66 Suppl 10():9-18.
2004: Adam H Corson; John E Barkenbus; David J Posey; Kimberly A Stigler; Christopher J McDougle
A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.
The Journal of clinical psychiatry 2004;65(11):1531-6.
2004: David J Posey; Deborah L Kem; Naomi B Swiezy; Thayne L Sweeten; Ryan E Wiegand; Christopher J McDougle
A pilot study of D-cycloserine in subjects with autistic disorder.
The American journal of psychiatry 2004;161(11):2115-7.
2004: Thayne L Sweeten; David J Posey; Christopher J McDougle
Brief report: autistic disorder in three children with cytomegalovirus infection.
Journal of autism and developmental disorders 2004;34(5):583-6.
2004: Thayne L Sweeten; David J Posey; Sudha Shankar; Christopher J McDougle
High nitric oxide production in autistic disorder: a possible role for interferon-gamma.
Biological psychiatry 2004;55(4):434-7.
2004: Emmeline Hazaray; Jason Ehret; David J Posey; Theodore A Petti; Christopher J McDougle
Intramuscular ziprasidone for acute agitation in adolescents.
Journal of child and adolescent psychopharmacology 2004;14(3):464-70.
2004: Kimberly A Stigler; David J Posey; Christopher J McDougle
Aripiprazole for maladaptive behavior in pervasive developmental disorders.
Journal of child and adolescent psychopharmacology 2004;14(3):455-63.
2004: David J Posey; Jessica I Puntney; Teresa M Sasher; Deborah L Kem; Christopher J McDougle
Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases.
Journal of child and adolescent psychopharmacology 2004;14(2):233-41.
2004: Kimberly A Stigler; Lael A Desmond; David J Posey; Ryan E Wiegand; Christopher J McDougle
A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.
Journal of child and adolescent psychopharmacology 2004;14(1):49-56.
2004: Kimberly A Stigler; Marc N Potenza; David J Posey; Christopher J McDougle
Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.
Paediatric drugs 2004;6(1):33-44.
2003: Thayne L Sweeten; Suzanne L Bowyer; David J Posey; Gary M Halberstadt; Christopher J McDougle
Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders.
Pediatrics 2003;112(5):e420.
2003: Thayne L Sweeten; David J Posey; Christopher J McDougle
High blood monocyte counts and neopterin levels in children with autistic disorder.
The American journal of psychiatry 2003;160(9):1691-3.
2003: Christopher J McDougle; Kimberly A Stigler; David J Posey
Treatment of aggression in children and adolescents with autism and conduct disorder.
The Journal of clinical psychiatry 2003;64 Suppl 4():16-25.
2002: Christopher J McDougle; David J Posey
Genetics of childhood disorders: XLIV. autism, part 3: psychopharmacology of autism.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(11):1380-3.
2002: Christopher J McDougle; Deborah L Kem; David J Posey
Case series: use of ziprasidone for maladaptive symptoms in youths with autism.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(8):921-7.
2002: James T McCracken; James J McGough; Bhavik Shah; Pegeen Cronin; Daniel Hong; Michael G Aman; L Eugene Arnold; Ronald L Lindsay; Patricia L Nash; Jill Hollway; Christopher J McDougle; David J Posey; Naomi B Swiezy; Arlene Kohn; Lawrence Scahill; Andres Martin; Kathleen Koenig; Fred Volkmar; Deirdre Carroll; Allison Lancor; Elaine Tierney; Jaswinder K Ghuman; Nilda M Gonzalez; Grados Marco; Benedetto Vitiello; Louise Ritz; Mark Davies; James Robinson; Don McMahon
Risperidone in children with autism and serious behavioral problems.
The New England journal of medicine 2002;347(5):314-21.
2002: Kimberly A Stigler; David J Posey; Christopher J McDougle
Recent advances in the pharmacotherapy of autism.
Expert review of neurotherapeutics 2002;2(4):499-510.
2002: Deborah L Kem; David J Posey; Christopher J McDougle
Priapism associated with trazodone in an adolescent with autism.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(7):758.
2002: Thayne L Sweeten; David J Posey; Anantha Shekhar; Christopher J McDougle
The amygdala and related structures in the pathophysiology of autism.
Pharmacology, biochemistry, and behavior 2002;71(3):449-55.
2001: Lawrence Scahill; James McCracken; Christopher J McDougle; Michael Aman; L Eugene Arnold; Elaine Tierney; Pegeen Cronin; Mark Davies; Jaswinder K Ghuman; N Gonzalez; Kathleen Koenig; Ronald L Lindsay; Andres Martin; James J McGough; David J Posey; Naomi B Swiezy; Fred Volkmar; Louise Ritz; Benedetto Vitiello
Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.
Journal of child and adolescent psychopharmacology 2001;11(4):377-88.
2001: David J Posey; K D Guenin; A E Kohn; Naomi B Swiezy; Christopher J McDougle
A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.
Journal of child and adolescent psychopharmacology 2001;11(3):267-77.
2000: Christopher J McDougle; L E Kresch; David J Posey
Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.
Journal of autism and developmental disorders 2000;30(5):427-35.
2000: David J Posey; Christopher J McDougle
The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.
Harvard review of psychiatry 2000;8(2):45-63.
2000: L Eugene Arnold; Michael G Aman; Andres Martin; Angie Collier-Crespin; Benedetto Vitiello; Elaine Tierney; R Asarnow; F Bell-Bradshaw; B J Freeman; P Gates-Ulanet; Ami Klin; James T McCracken; Christopher J McDougle; James J McGough; David J Posey; Lawrence Scahill; Naomi B Swiezy; Louise Ritz; Fred Volkmar
Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology.
Journal of autism and developmental disorders 2000;30(2):99-111.
2000: Christopher J McDougle; Lawrence Scahill; James T McCracken; Michael G Aman; Elaine Tierney; L Eugene Arnold; B J Freeman; Andres Martin; James J McGough; Pegeen Cronin; David J Posey; Mark A Riddle; Louise Ritz; Naomi B Swiezy; Benedetto Vitiello; Fred Volkmar; Nicholas A Votolato; P Walson
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
Child and adolescent psychiatric clinics of North America 2000;9(1):201-24.
1999: David J Posey; Kelda H Walsh; G A Wilson; Christopher J McDougle
Risperidone in the treatment of two very young children with autism.
Journal of child and adolescent psychopharmacology 1999;9(4):273-6.